Melasma Treatment Step by Step: From Diagnosis to Procedures

You apply SPF every day, yet brown areas on your cheeks or above your lip remain, and it is hard to know whether you need a cream, peel or device. Melasma treatment is usually stepwise: confirm the diagnosis, protect against UV and visible light, choose a tolerable topical treatment, and only then consider additional approaches. Patches cannot always be removed quickly or permanently: melasma is often long-lasting and prone to recurrence.

That does not mean endlessly buying new skincare. A more realistic goal is reducing the contrast of patches and managing recurrence with a routine you can maintain without constantly irritating your skin. If the pigmentation does not bother you, treatment is optional.

Where do you start if the patches look like melasma?

Melasma often forms blurred, fairly symmetrical brown or grey-brown areas on the forehead, cheekbones, bridge of the nose or upper lip. It is more common in women and may emerge in pregnancy, during hormonal changes or after sun exposure. But the same brown colour does not make every patch melasma. Post-inflammatory marks, sunspots (solar lentigines), drug-induced pigment and some skin disorders need different assessment.

If one patch is isolated, changing, bleeding, intensely itchy or has irregular borders, do not try to bleach it first. See a dermatologist in person, with dermoscopy if needed. Even a typical symmetrical pattern should ideally be diagnosed before prescription agents or devices. A Wood's lamp can sometimes help assess the pigment pattern, but no examination turns treatment into a guaranteed outcome.

At the consultation mention when patches started; changes during pregnancy, after starting hormonal contraception or after sun exposure; any acids and retinoids previously used; and episodes of stinging. This helps distinguish persistent melasma from irritation and additional post-inflammatory pigmentation. Buying a procedure before having that conversation rarely saves time.

The foundation that an expensive procedure cannot replace

Sunlight's ultraviolet component promotes pigmentation, and visible light can also aggravate melasma, especially in darker phototypes. Choose broad-spectrum sunscreen SPF 30 or above, and while outdoors reapply about every two hours and after swimming or heavy sweating, following the product directions. A broad-brimmed hat, shade and avoiding tanning beds help where sunscreen alone is insufficient.

For melasma, the detail missing from generic SPF advice matters: tinted products with iron oxides help protect against visible light. An SPF rating alone does not mean such protection. Choose a shade you can comfortably apply in adequate amounts; unpleasant products often become skipped steps. There is no reason to fear smartphone screens the same way as strong sunlight: current expert guidance does not support equating routine phone-light exposure with solar exposure.

Keep skincare gentle. Persistent stinging, redness or dryness from a cleanser, serum or brightening cream does not mean pigment is being pushed out. Irritation may worsen darkening. A milder cleanser and moisturizer can be important to success. Makeup camouflage is compatible with sensible treatment and can help you avoid anxiously inspecting your face every morning.

What products and procedures might a dermatologist offer?

This comparison shows the purpose of each option. It is not a prescription: formulas, strengths, duration and contraindications depend on examination. The strongest cream means little if it causes intolerable irritation.

Option	When it may be discussed	What to watch for
Tinted SPF, shade and gentle skincare	Almost every stage, including maintenance.	Consistency matters; protection reduces new darkening but does not guarantee old patches will fade quickly.
Azelaic acid and other individual topical lightening agents	When a gentler approach or particular tolerability is relevant.	Improvement is usually gradual; dryness, tingling and irritation may occur.
Prescription hydroquinone	To reduce pigment production under medical supervision.	Dosing and adverse effects need monitoring; prolonged unsupervised use risks persistent abnormal skin pigmentation.
Triple combination: hydroquinone, tretinoin and a corticosteroid	One of the researched topical choices for suitable patients.	Not for indefinite uncontrolled use: irritation and complications from prolonged steroid exposure can occur.
Superficial chemical peels	Sometimes as an addition to a home regimen for selected skin.	Irritation can create more pigmentation; more peeling does not necessarily mean better results.
Laser and light procedures	Selected difficult cases after assessing benefit and risks.	Relapse and post-inflammatory colour changes are possible; not a universal first-line choice.
Oral tranexamic acid	Selected persistent cases at a dermatologist's discretion after risk assessment.	Use for melasma is off-label in some countries; serious thrombotic risks are possible with certain conditions and medicines.

It is important to distinguish doctor-prescribed hydroquinone from unknown bleaching creams sold online. The US FDA warns that over-the-counter hydroquinone skin-lightening products are not legally approved for sale in the United States and that serious effects include ochronosis—sometimes persistent abnormal darkening. This is US regulation, not a statement about Armenian law. Do not copy another person's dosing schedule or mix multiple strong products hoping for quick changes.

A triple combination can work well, but tretinoin is a retinoid and prolonged inappropriate corticosteroid use may damage skin. You therefore need a plan for what comes after the main course, not a permanent prescription. A gentler option is not necessarily worse long term: chronic irritation can make melasma harder to control.

How long will it take, and when should you reconsider the plan?

Melasma lightens gradually, especially when long-standing. The American Academy of Dermatology describes noticeable improvement with consistent treatment as taking 3–12 months, sometimes longer. That does not mean every cream should be applied for a full year: some prescription ingredients are used in limited courses, and tolerability may need earlier review. An international consensus recommends reviewing response to a chosen initial treatment after about 8–12 weeks. A clinician decides whether to adjust it according to progress and safety.

Follow-up stage	What to assess instead of a promised percentage improvement
Before starting	Comparable daylight photos, a list of products and triggers, and your chosen sunscreen.
First weeks	Skin comfort, sun-protection consistency, dryness and stinging; do not increase doses yourself.
Around 8–12 weeks	Whether patch contrast has truly lessened in matched photos, and whether to adjust the plan.
Subsequent months	Can improvement be maintained with a gentler regimen, and what happens during sunny months?

Do not judge progress from one day after a holiday or a mirror under changing lighting. Increased contrast can reflect more sun exposure, a newly irritating product or makeup differences. But genuine darkening should not be ignored. Keep a short, clear skincare diary and take photos to the doctor: it may help distinguish lack of response from an unsuitable regimen.

What changes with pregnancy, contraception or a history of blood clots?

Melasma may appear for the first time in pregnancy and sometimes become less visible after birth. Tell the clinician if you are pregnant or planning pregnancy before medicines or procedures are prescribed. Topical retinoids, including tretinoin, are generally recommended to be avoided during pregnancy; discuss every lightening formula with your dermatologist and obstetrician. Sun protection and gentle care are sensible starting points during pregnancy; azelaic acid may be discussed with those clinicians as a possible topical option, not self-prescribed. Do not replace one prescription active with another based on social media. During breastfeeding too, the safety of each specific plan must be assessed individually; the label cosmetic tells you nothing about safety.

Oral tranexamic acid deserves its own discussion. It is studied for difficult melasma, but US-authorized tablets have other indications; melasma use must not be described as routinely approved. The US prescribing information warns about blood clots and contraindications, including combined hormonal contraception, previous thromboembolism or an underlying tendency to clot. Before prescribing it, the clinician asks about clots, migraine and vision symptoms, medicines, pregnancy plans and other risk factors. Do not take these tablets on your own for pigmentation.

If you suspect hormonal contraception contributes, do not stop it without talking to the prescriber: the decision must account for why it was prescribed, not only the skin. Reducing pigmentation should not create a different medical danger.

If nothing helps, should you consider a peel or laser?

Sometimes skincare is well tolerated and sunscreen use consistent, yet patches remain visible. First the clinician checks for a different diagnosis, irritation or inconsistent sun protection. They may then discuss changing topical agents or combining therapies. Procedures can be added in some cases but do not replace daily light protection.

Laser treatment for melasma requires careful selection: a temporary improvement may be followed by renewed darkening or new pigmentation. A peel may help superficial pigment, but the amount of injury matters. A deeper procedure does not necessarily give a longer-lasting or more natural result. If you expect an even tone without future skincare, discuss that expectation before selecting treatment.

It can be reassuring to agree in advance on limits: how much time you can devote to skincare, what degree of change matters, whether you accept visible irritation and whether an upcoming event or photo shoot makes experimentation undesirable. You do not have to act quickly because someone else notices the patches. Continuing sun protection and deciding later is also reasonable.

What reactions are expected, and when do you need medical care?

Brief mild stinging with a new topical agent can happen, but increasing burning, marked redness, cracks, weeping skin or swelling are not signs that lightening is working. Stop a suspected irritating cosmetic and contact your clinician; for a prescription medicine, follow professional advice about stopping or switching it. Blisters, severe pain, increasing redness, pus or fever after a procedure call for prompt medical assessment.

If sudden breathlessness, chest pain, one-sided leg swelling or pain, or new acute visual problems occur while taking oral tranexamic acid, stop taking it and seek emergency medical care immediately; do not attribute these symptoms to routine cosmetic care. Agree on your individual action plan before starting the medicine. Even a rare serious risk matters more than a promise of faster lightening.

How do you choose a plan that fits you?

Ask the dermatologist to explain the diagnosis in plain language and why other causes have been ruled out. Ask why one active ingredient was chosen over another, what to do if irritation develops, when to review progress, how maintenance works and which options are inappropriate given pregnancy, medicines and your skin's response to inflammation. If a device is suggested, ask specifically about relapse, social downtime and medical support for complications.

Compare the cost of the whole plan, not only one jar or session: consultations, follow-ups, sun protection and maintenance can add up. Generic articles cannot reliably establish local prices or which medicines are stocked. Be wary of forever and suitable for everyone promises: realistic limits matter more than polished sales charts.

For one manageable next step, have the diagnosis checked and build a tolerable sun-protection routine. Then discuss one considered treatment plan instead of introducing several harsh actives at once. The goal is comfortable day-to-day skin, not an endless pursuit of perfectly uniform colour.

Additional questions

Does every woman with melasma need hormone tests?

Not necessarily. Melasma is usually identified from the skin examination and history. Extra testing depends on associated symptoms, medicines and the clinical situation. Pigmented patches alone do not imply everyone needs the same hormone panel.

How is treating melasma different from changing your natural skin colour?

The goal is to reduce abnormal contrast and bring patches closer to your usual tone, not to lighten all your skin. If a proposed plan treats unaffected skin with harsh products, ask why and how unwanted pigment loss will be monitored.